Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 249: A New Vision for NC Pediatric Care with Andy Willis of North Carolina Children’s
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 248: Fighting Addiction and Expanding Access to Treatment with Sara Howe and Morgan Coyner of APNC
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 236: Advocating for Accessible Diagnoses with Sydney Severance of Operation Upright
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 207: Long COVID Research & Treatments with Dr. Kashyap Patel of Carolina Blood & Cancer Care Associates
Early Returns Podcast with Jan Baran - Josh Gerstein: SCOTUS, the Presidential Immunity Case Fallout, and the Dobbs Case Leak Investigation
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 189: Student Mental Health with Dr. Stephanie Irby Coard, UNC Professor
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 179: Obesity Effects on the Workforce & Economy with Tim Dall, Healthcare Economist
Podcast: Post-Dobbs - One Year Later - Diagnosing Health Care
Podcast: Post-Dobbs - Considerations for Clinical Trials and Research - Diagnosing Health Care
In the Boardroom With Resnick and Fuller - Episode 2
Let's Talk About the Constitutional Aspects of the Dobbs Decision
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 116: Michael Carlin, Manager, Engage HCP by TrialCard
Compliance Perspectives: Providing Patient Access to Personal Health Data
Passage of Federal Right-to-Try law poses risks and opportunities for patients and the biopharmaceutical industry
K&L Gates Triage: An Insider’s Perspective on the Health Care Debate in Washington, DC
In 2026, there are fewer prescription drug plans in Medicare Part D and higher premiums, even when offset by a multi-billion-dollar government premium subsidy; this degradation of the Part D market is likely attributable to...more
Effective October 1, 2025, Connecticut’s Public Act 25-97 introduced a significant change for health systems and providers regarding patient payment practices....more
In this edition, we look at the rise in the rates of physician attrition across specialties, the impact the federal government shutdown had on telehealth programs, how medical malpractice reforms have affected emergency...more
Government shutdown breaks record. As the shutdown passed the 35-day record, negotiations to reopen the government continued....more
Effective October 1, 2025, the US Department of Health and Human Services (HHS) implemented grants policy statement (GPS) v2.0, consistent with its prior adoption of 2 CFR part 200 with HHS-specific provisions at 2 CFR part...more
The Department of Labor, Department of Health and Human Services, and the Internal Revenue Service (IRS) (collectively, the “Agencies”) recently released FAQs about Implementation of the Affordable Care Act Part 72, which...more
At its October 2025 board meeting, the Alabama Board of Pharmacy (the “Board”) voted to remove a requirement that new wholesale distributor applicants sign an affidavit affirming that products distributed in Alabama will only...more
If you are taking a drug that has been recalled, it is important to make sure you know what the recall means for you. Some drug recalls are far more serious than others, and it is important not to stop taking a drug if taking...more
On September 18 and 19, 2025, the Advisory Committee on Immunization Practices (“ACIP”) of the Centers for Disease Control and Prevention (“CDC”) revised its recommendations regarding the COVID-19 vaccine and the combined...more
Since the last update regarding non-compete agreements in healthcare, there have been recent developments over the past few weeks, both in the courts and with the Federal Trade Commission (FTC), that have brought some clarity...more
As of September 30, several temporary Medicare telehealth flexibilities that were put in place during the COVID-19 pandemic officially came to an end. One of the most significant changes involves the site requirement for...more
The pharmaceutical industry has benefitted from a generally duty-free import environment for decades, allowing pharmaceutical manufacturers and importers to develop extensive, multi-jurisdictional supply chains optimized for...more
Alabama’s age of medical consent is rising from 14 to 16 beginning October 1, following the passage of amendments and additions to existing age of consent state laws in the 2025 legislative session. For medical practices, the...more
On September 17, California Governor Gavin Newsom signed Assembly Bill 144 (AB 144) into law, a move in response to recent changes in immunization recommendations by the U.S. Food and Drug Administration (FDA)....more
As of September 2025, Texas maintains its status as a medical-only, low-THC market, governed by a stringent regulatory framework overseen by the Department of Public Safety (“DPS”). ...more
On July 31, 2025, the White House released a fact sheet discussing additional steps taken by the Trump administration surrounding efforts towards lowering drug prices for Americans. ...more
Recent public statements by President Trump have reignited discussion about the possibility of federal cannabis rescheduling. During an August 11th press exchange at the White House, the President confirmed that his...more
he Food and Drug Administration (FDA) issued a press release on Sept. 9 announcing a “crackdown” on direct-to-consumer (DTC) pharmaceutical advertising and promising “sweeping reforms" in line with President Trump's same-day...more
GLP-1 receptor agonists (GLP-1s) such as semaglutide, and dual agonists like tirzepatide, are transforming obesity treatment and reshaping the US health care landscape. Originally developed to manage type 2 diabetes, these...more
Welcome back to the Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, we focus our attention on three states, each of which is having a different issue with cannabis. In Texas,...more
The Massachusetts law permitting pharmacies and pharmaceutical manufacturers to offer drug discounts to consumers, which was set to expire on January 1, 2026, has recently been extended to January 1, 2031....more
Heather and Lauren are joined by Andy Willis, Executive Chief Planning and Development Officer of North Carolina Children’s, a new freestanding children’s hospital being developed through a historic partnership between UNC...more
The US Department of Justice has proposed legislation to the US Congress that would, if enacted, create a private right of action against healthcare professionals who provide gender-affirming care to children. The proposal...more
The U.S. Food and Drug Administration (FDA) announced a new process called “Rare Disease Evidence Principles” (RDEP), under which eligible drugs and biologics for ultra-rare diseases caused by known genetic defects will...more
The New York Attorney General’s office recently announced an agreement with MVP Health Care under which the insurer will pay $250,000 in penalties, fees, and costs to the state for maintaining an inaccurate mental health...more